The Role of Pathology-Based Methods in Qualitative and Quantitative Approaches to Cancer Immunotherapy

Immune checkpoint inhibitors, including those concerning programmed cell death 1 (PD-1) and its ligand (PD-L1), have revolutionised the cancer therapy approach in the past decade. However, not all patients benefit from immunotherapy equally. The prediction of patient response to this type of therapy...

Ausführliche Beschreibung